Alfred Franzblau1, Robert A Werner, Joanne Yihan. 1. Department of Environmental Health Sciences, School of Public Health, College of Engineering, University of Michigan, Ann Arbor, Michigan, USA. afranz@uich.edu
Abstract
UNLABELLED: Is not hiring otherwise-qualified workers who have an abnormal post-offer preplacement (POPP) median nerve test a cost-effective strategy to reduce workers' compensation expenses related to carpal tunnel syndrome (CTS)? We performed a retrospective dynamic cohort study based on 2150 workers hired at a company between January 1996 and December 2001 and who underwent POPP median nerve testing. Workers were followed until they left the company or until follow-up ended in May 2003. RESULTS: Thirty-five cases of work-related CTS occurred during follow-up, and 9.13 cases could have been avoided. However, if the company had not hired workers with abnormal POPP nerve test results, it would have suffered a net loss of $357,353. CONCLUSION: Not hiring workers with abnormal POPP nerve tests to reduce costs of work-related CTS is not a cost-effective strategy for employers.
UNLABELLED: Is not hiring otherwise-qualified workers who have an abnormal post-offer preplacement (POPP) median nerve test a cost-effective strategy to reduce workers' compensation expenses related to carpal tunnel syndrome (CTS)? We performed a retrospective dynamic cohort study based on 2150 workers hired at a company between January 1996 and December 2001 and who underwent POPP median nerve testing. Workers were followed until they left the company or until follow-up ended in May 2003. RESULTS: Thirty-five cases of work-related CTS occurred during follow-up, and 9.13 cases could have been avoided. However, if the company had not hired workers with abnormal POPP nerve test results, it would have suffered a net loss of $357,353. CONCLUSION: Not hiring workers with abnormal POPP nerve tests to reduce costs of work-related CTS is not a cost-effective strategy for employers.
Authors: Ann Marie Dale; Bethany T Gardner; Skye Buckner-Petty; Jaime R Strickland; Bradley Evanoff Journal: J Occup Environ Med Date: 2016-12 Impact factor: 2.162
Authors: Ann Marie Dale; Folasade Agboola; Amber Yun; Angelique Zeringue; Muhammed T Al-Lozi; Bradley Evanoff Journal: PM R Date: 2014-10-15 Impact factor: 2.298
Authors: Ann Marie Dale; Bethany T Gardner; Angelique Zeringue; Robert Werner; Alfred Franzblau; Bradley Evanoff Journal: J Occup Environ Med Date: 2014-08 Impact factor: 2.162
Authors: Frederieke G Schaafsma; Norashikin Mahmud; Michiel F Reneman; Jean-Baptiste Fassier; Franciscus H W Jungbauer Journal: Cochrane Database Syst Rev Date: 2016-01-12
Authors: Fraser W Gaspar; Roman Kownacki; Catherine S Zaidel; Craig F Conlon; Kurt T Hegmann Journal: J Occup Environ Med Date: 2017-12 Impact factor: 2.162
Authors: Christina Bach Lund; Sigurd Mikkelsen; Lau Caspar Thygesen; Gert-Åke Hansson; Jane Frølund Thomsen Journal: Occup Environ Med Date: 2019-06-12 Impact factor: 4.402